MarketsSingle-source
2.0
Sunshine Biopharma Inc. reports executive or director departure/appointment
SEC EDGAR 8-K FilingsLO·US·about 22 hours ago
MarketsSingle-sourceLow
2.0
Outset Medical files 8-K regarding executive or director departure
Outset Medical, Inc. has filed an 8-K report under Item 5.02, indicating a change in corporate leadership or board composition. The specific identity of the departing or incoming individual and the material impact on company strategy remain to be detailed in the full filing text.
Score Breakdown
Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1
Related signals
8 foundMarketsSingle-source
2.0
Jupiter Neurosciences, Inc. files 8-K regarding material agreement and executive changes
SEC EDGAR 8-K FilingsLO·US·2 days ago
MarketsSingle-source
2.0
National Health Investors Inc. reports executive or director transition
SEC EDGAR 8-K FilingsLO·US·2 days ago
MarketsNotableSingle-sourceDeveloping
5.4
SEC Proposes Easing Audit and Disclosure Requirements for Public Companies
New York Times·US·1 day ago
MarketsNotableSingle-source
5.1
Intrusion Inc. files 8-K disclosing material agreement, asset acquisition, and financial obligations
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsNotableConfirmed
5.1
Affirm Holdings files 8-K reporting financial results and executive leadership changes
SEC EDGAR 8-K FilingsLO·US·2 days ago
MarketsSingle-source
2.0
K2 Capital Acquisition Corp files 8-K regarding material definitive agreement
SEC EDGAR 8-K FilingsLO·US·2 days ago
MarketsSingle-source
2.0
Constellation Acquisition Corp I Files 8-K Regarding Direct Financial Obligation
SEC EDGAR 8-K FilingsLO·US·about 21 hours ago